CHO Pharma (Taiwan) Performance
| 6586 Stock | TWD 50.90 0.50 0.97% |
The firm shows a Beta (market volatility) of 0.33, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, CHO Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding CHO Pharma is expected to be smaller as well. At this point, CHO Pharma has a negative expected return of -0.24%. Please make sure to confirm CHO Pharma's standard deviation, total risk alpha, maximum drawdown, as well as the relationship between the jensen alpha and treynor ratio , to decide if CHO Pharma performance from the past will be repeated in the future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days CHO Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors. ...more
| Fifty Two Week Low | 28.90 | |
| Fifty Two Week High | 42.13 |
CHO |
CHO Pharma Relative Risk vs. Return Landscape
If you would invest 5,950 in CHO Pharma on September 4, 2024 and sell it today you would lose (860.00) from holding CHO Pharma or give up 14.45% of portfolio value over 90 days. CHO Pharma is generating negative expected returns and assumes 1.3409% volatility on return distribution over the 90 days horizon. Simply put, 11% of stocks are less volatile than CHO, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
CHO Pharma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CHO Pharma's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as CHO Pharma, and traders can use it to determine the average amount a CHO Pharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.178
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 6586 |
Estimated Market Risk
| 1.34 actual daily | 11 89% of assets are more volatile |
Expected Return
| -0.24 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.18 actual daily | 0 Most of other assets perform better |
Based on monthly moving average CHO Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CHO Pharma by adding CHO Pharma to a well-diversified portfolio.
CHO Pharma Fundamentals Growth
CHO Stock prices reflect investors' perceptions of the future prospects and financial health of CHO Pharma, and CHO Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CHO Stock performance.
About CHO Pharma Performance
Evaluating CHO Pharma's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if CHO Pharma has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CHO Pharma has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about CHO Pharma performance evaluation
Checking the ongoing alerts about CHO Pharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for CHO Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CHO Pharma generated a negative expected return over the last 90 days |
- Analyzing CHO Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CHO Pharma's stock is overvalued or undervalued compared to its peers.
- Examining CHO Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CHO Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CHO Pharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CHO Pharma's stock. These opinions can provide insight into CHO Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for CHO Stock Analysis
When running CHO Pharma's price analysis, check to measure CHO Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CHO Pharma is operating at the current time. Most of CHO Pharma's value examination focuses on studying past and present price action to predict the probability of CHO Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CHO Pharma's price. Additionally, you may evaluate how the addition of CHO Pharma to your portfolios can decrease your overall portfolio volatility.